Amari Ingredients: CBD

Hemp Derived Cannabidiol (CBD)

CBD Overview

Cannabidiol (CBD) and other cannabinoids have been all over the news and popular press recently for their therapeutic benefits and potential for treating a wide range of indications; from pain and inflammation to anxiety and neurodegenerative diseases. The reality is that more is unknown than known about the therapeutic benefits of CBD and other cannabinoids and how they impact the endocannabinoid system. The endocannabinoid system plays a factor in regulating a variety of functions in the body; pain, appetite, sleep and immune system response.

Amari views CBD as an enabling ingredient supporting the effectiveness of the clinically proven turmeric, ashwagandha and other botanical ingredients we intentionally select for our customers. We are committed to educating our consumers about powerful plant-based solutions to everyday aches and pains. Amari will continue to provide updates on applications for CBD and other cannabinoids as they are validated by the research community.

Amari sources our water-soluble, broad spectrum CBD from US grown industrial hemp that is verified to be THC free. The emulsification process preserves the delicate cannabinoids and delivers them in a highly bioavailable format for your body to utilize.

CBD Benefits

Below is a list of where the research is headed on the beneficial properties of CBD:
Improves inflammation response in the body
Supports improved mood and reduced anxiety
Anti-oxidant properties

Learn More…

Cannabinoids and CBD are in the early phases of research, a few clinical studies and journal articles are available. Please click the link for a PDF.
An Overview of the Endocannabinoid System - A comprehensive overview of the research on this hormone signaling system in the body
Cannabidiol and Anxiety - CBD reduced anxiety in a clinical trial simulating public speaking
Pharmacotherapeutic Considerations for use of Cannabinoids to Relieve Pain - Review of randomized control trials to assess the efficacy of cannabis preparations for relieving pain in patients with malignant diseases.
Preclinical and Clinical Evidence Supporting Use of Cannabidiol (CBD) in Psychiatry – Review of Preclinical and Clinical Studies using CBD to develop new strategies in treating mental diseases.

Additional Resources…

Increasing Use of Cannabis Among Older Americans – Study outlining the growing popularity of cannabis among older Americans and the factors behind this growth and the implications.